Literature DB >> 12943152

Cost-effectiveness of colorectal cancer screening in the average risk population.

Moshe Leshno1, Zamir Halpern, Nadir Arber.   

Abstract

Colorectal cancer (CRC) is a leading cause of cancer death in North America and in Israel. Risk of CRC increases exponentially with age starting at the age of 50 years. Therefore, people older than 50 years are being considered as an average risk population for CRC. The objective of this study was to obtain an improved assessment of the cost-effectiveness analysis of screening for CRC in the average risk population by using a more accurate technique, namely the Partially Observed Markov Decision Process (POMDP). We conducted a cost-effectiveness analysis within the specific probability rates and costs in Israel. This study revealed that it is highly cost-effective to screen average-risk asymptomatic individuals.

Entities:  

Mesh：

Year:  2003        PMID： 12943152     DOI： 10.1023/a:1024488007043

Source DB:  PubMed          Journal:  Health Care Manag Sci        ISSN： 1386-9620


  43 in total

1.  Growth of colorectal polyps: recovery and evaluation of unresected polyps of less than 10 mm, 1 year after detection.

Authors:  B Hofstad; M Vatn; S Larsen; M Osnes
Journal:  Scand J Gastroenterol       Date:  1994-07       Impact factor: 2.423

2.  Colorectal polyps in the Upper Galilee.

Authors:  Y Niv
Journal:  Isr J Med Sci       Date:  1989-06

3.  Detecting colorectal cancer in stool with the use of multiple genetic targets.

Authors:  S M Dong; G Traverso; C Johnson; L Geng; R Favis; K Boynton; K Hibi; S N Goodman; M D'Allessio; P Paty; S R Hamilton; D Sidransky; F Barany; B Levin; A Shuber; K W Kinzler; B Vogelstein; J Jen
Journal:  J Natl Cancer Inst       Date:  2001-06-06       Impact factor: 13.506

4.  Cost-utility of one-time colonoscopic screening for colorectal cancer at various ages.

Authors:  R M Ness; A M Holmes; R Klein; R Dittus
Journal:  Am J Gastroenterol       Date:  2000-07       Impact factor: 10.864

5.  Cancer statistics, 1998.

Authors:  S H Landis; T Murray; S Bolden; P A Wingo
Journal:  CA Cancer J Clin       Date:  1998 Jan-Feb       Impact factor: 508.702

6.  Cost-effectiveness of colonoscopy in screening for colorectal cancer.

Authors:  A Sonnenberg; F Delcò; J M Inadomi
Journal:  Ann Intern Med       Date:  2000-10-17       Impact factor: 25.391

7.  Polyps of the large intestine in Northern Norway.

Authors:  T J Eide; H Stalsberg
Journal:  Cancer       Date:  1978-12       Impact factor: 6.860

8.  Do characteristics of adenomas on flexible sigmoidoscopy predict advanced lesions on baseline colonoscopy?

Authors:  T M Zarchy; D Ershoff
Journal:  Gastroenterology       Date:  1994-06       Impact factor: 22.682

9.  Natural history of untreated colonic polyps.

Authors:  S J Stryker; B G Wolff; C E Culp; S D Libbe; D M Ilstrup; R L MacCarty
Journal:  Gastroenterology       Date:  1987-11       Impact factor: 22.682

10.  Incidence and recurrence rates of colorectal adenomas: a prospective study.

Authors:  A I Neugut; J S Jacobson; H Ahsan; J Santos; G C Garbowski; K A Forde; M R Treat; J Waye
Journal:  Gastroenterology       Date:  1995-02       Impact factor: 22.682
View more
  12 in total

1.  Probability model for estimating colorectal polyp progression rates.

Authors:  Chaitra Gopalappa; Selen Aydogan-Cremaschi; Tapas K Das; Seza Orcun
Journal:  Health Care Manag Sci       Date:  2010-10-05

Review 2.  CT colonography and cost-effectiveness.

Authors:  Ifigeneia Mavranezouli; James E East; Stuart A Taylor
Journal:  Eur Radiol       Date:  2008-06-27       Impact factor: 5.315

3.  Prevention, screening and treatment of colorectal cancer: a global and regional generalized cost effectiveness analysis.

Authors:  Gary M Ginsberg; Stephen S Lim; Jeremy A Lauer; Benjamin P Johns; Cecilia R Sepulveda
Journal:  Cost Eff Resour Alloc       Date:  2010-03-17

4.  Cost-effectiveness of colorectal cancer screening - an overview.

Authors:  Iris Lansdorp-Vogelaar; Amy B Knudsen; Hermann Brenner
Journal:  Best Pract Res Clin Gastroenterol       Date:  2010-08       Impact factor: 3.043

5.  Cost-Effectiveness Evaluation of EHR: Simulation of an Abdominal Aortic Aneurysm in the Emergency Department.

Authors:  Ofir Ben-Assuli; Amitai Ziv; Doron Sagi; Avinoah Ironi; Moshe Leshno
Journal:  J Med Syst       Date:  2016-04-25       Impact factor: 4.460

6.  Applying reinforcement learning techniques to detect hepatocellular carcinoma under limited screening capacity.

Authors:  Elliot Lee; Mariel S Lavieri; Michael L Volk; Yongcai Xu
Journal:  Health Care Manag Sci       Date:  2014-10-12

Review 7.  Cost-effectiveness of colorectal cancer screening.

Authors:  Iris Lansdorp-Vogelaar; Amy B Knudsen; Hermann Brenner
Journal:  Epidemiol Rev       Date:  2011-06-01       Impact factor: 6.222

8.  Cost-effectiveness analysis of colorectal cancer screening with stool DNA testing in intermediate-incidence countries.

Authors:  Grace Hui-Min Wu; Yi-Ming Wang; Amy Ming-Fang Yen; Jau-Min Wong; Hsin-Chih Lai; Jane Warwick; Tony Hsiu-Hsi Chen
Journal:  BMC Cancer       Date:  2006-05-24       Impact factor: 4.430

9.  Cost-effectiveness simulation and analysis of colorectal cancer screening in Hong Kong Chinese population: comparison amongst colonoscopy, guaiac and immunologic fecal occult blood testing.

Authors:  Carlos K H Wong; Cindy L K Lam; Y F Wan; Daniel Y T Fong
Journal:  BMC Cancer       Date:  2015-10-15       Impact factor: 4.430

10.  Cost-effectiveness of colorectal cancer screening in Ukraine.

Authors:  Nelya Melnitchouk; Djøra I Soeteman; Jennifer S Davids; Adam Fields; Joshua Cohen; Farzad Noubary; Andrey Lukashenko; Olena O Kolesnik; Karen M Freund
Journal:  Cost Eff Resour Alloc       Date:  2018-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.